Skip to content
10-Q

Quarterly Report

MiNK Therapeutics, Inc. INKT

0001193125-25-282905

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 13, 2025 4.69M sh
Shares Diluted Q3 2025 · Sep 30, 2025 4.44M sh
Shares Diluted Q3 2025 · Sep 30, 2025 4.13M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 3.95M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 3.71M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$3.85M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$7.83M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $14.28M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $4.58M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$13.51M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$25.19M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$21.79M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$19.59M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$17.55M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$16.58M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$20.3M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$18.06M
Current Liabilities Q3 2025 · Sep 30, 2025 $13.43M
Current Liabilities Q3 2025 · Dec 31, 2024 $6.96M
Current Assets Q3 2025 · Sep 30, 2025 $14.53M
Current Assets Q3 2025 · Dec 31, 2024 $4.99M
Total Assets Q3 2025 · Sep 30, 2025 $14.96M
Total Assets Q3 2025 · Dec 31, 2024 $5.72M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.65
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.39
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$0.46
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$2.24
Eps Basic Q3 2025 · Sep 30, 2025 −$0.65
Eps Basic Q3 2025 · Sep 30, 2025 −$2.39
Eps Basic restated Q3 2025 · Sep 30, 2024 −$0.46
Eps Basic restated Q3 2025 · Sep 30, 2024 −$2.24
Sga Expense Q3 2025 · Sep 30, 2025 $1.85M
Sga Expense Q3 2025 · Sep 30, 2025 $4.97M
Sga Expense Q3 2025 · Sep 30, 2024 $1.16M
Sga Expense Q3 2025 · Sep 30, 2024 $3.51M
Rd Expense Q3 2025 · Sep 30, 2025 $1.14M
Rd Expense Q3 2025 · Sep 30, 2025 $4.24M
Rd Expense Q3 2025 · Sep 30, 2024 $540.64K
Rd Expense Q3 2025 · Sep 30, 2024 $4.93M
Net Income Q3 2025 · Sep 30, 2025 −$2.89M
Net Income Q3 2025 · Sep 30, 2025 −$9.89M
Net Income Q3 2025 · Jun 30, 2025 −$4.24M
Net Income Q3 2025 · Mar 31, 2025 −$2.77M
Net Income Q3 2025 · Sep 30, 2024 −$1.81M
Net Income Q3 2025 · Sep 30, 2024 −$8.32M
Net Income Q3 2025 · Jun 30, 2024 −$2.7M
Net Income Q3 2025 · Mar 31, 2024 −$3.81M
Operating Income Q3 2025 · Sep 30, 2025 −$3.18M
Operating Income Q3 2025 · Sep 30, 2025 −$9.94M
Operating Income Q3 2025 · Sep 30, 2024 −$1.88M
Operating Income Q3 2025 · Sep 30, 2024 −$8.79M